Company Number: 13101337

Analysis Date: 2025-07-20 15:28 UTC

Financial Health Assessment of MONISVICK LIMITED

---

1. Financial Health Score: D

Explanation:
The company's financial statements reveal a troubling trend of negative net assets (liabilities exceeding assets) over the last two reported years (2023 and 2024). This "symptom" suggests financial distress, akin to a patient showing signs of organ failure. Although the company remains active, the lack of positive working capital and shareholder equity raises concerns about its sustainability without intervention.

---

2. Key Vital Signs (Critical Metrics)

Metric	2024 (£)	2023 (£)	Interpretation
Current Assets	12	985	Extremely low liquidity; "weak pulse"
Current Liabilities	1,873	2,696	High short-term obligations; "pressure"
Net Current Assets	-1,861	-1,711	Negative working capital; "significant blockage"
Total Net Assets	-1,861	-1,711	Negative equity; "critical condition"
Share Capital	2	2	Minimal capital base; "thin blood supply"
Employees	0	0	No staff on payroll; potential "dormancy"

• Negative Net Current Assets: The company owes more in the short term than it owns in liquid assets, which compromises its ability to meet immediate debts.
• Negative Net Assets: Shareholder funds are negative, meaning liabilities exceed total assets, an indicator of insolvency risk.
• Minimal Share Capital: Just £2, which provides negligible financial buffer.
• No Employees: The company currently has no staff, which might reflect operational inactivity or outsourcing.

---

3. Diagnosis: Overall Financial Condition

The company shows clear symptoms of financial distress:

• Liquidity Crisis: The very low current assets (cash or equivalents) relative to current liabilities suggest MONISVICK LIMITED struggles to pay its short-term debts as they fall due.
• Balance Sheet Weakness: Negative net assets indicate the company’s total obligations surpass its resources, a critical warning sign often associated with insolvency risk.
• Operational Dormancy: Zero employees and minimal assets hint at potentially low or no active trading, reducing revenue inflow and exacerbating financial stress.
• Declining Financial Health: The net current assets have deteriorated from substantially positive levels in 2021/22 (_{£7,900) to deeply negative by 2023/24 (}-£1,860), showing worsening financial vitality.

In summary, the company is akin to a patient with chronic illness untreated for some time; without intervention, the prognosis is poor.

---

4. Prognosis: Future Financial Outlook

Given the current trajectory and financial indicators:

• Without corrective action, the company faces a risk of insolvency or forced liquidation.
• The liquidity crunch limits operational flexibility and ability to invest or grow.
• The absence of employees may hinder revenue generation unless the business model is non-labour intensive.
• If the controlling director can inject capital or reduce liabilities, the company’s "health" could stabilize.
• Continued negative net assets may deter lenders, suppliers, and investors, worsening credit terms and operational viability.

---

5. Recommendations: Actions to Improve Financial Wellness

1. Immediate Cash Injection:
   Infuse working capital to improve liquidity and reduce current liabilities, akin to administering emergency fluids to stabilize a patient.

2. Cost Control and Liability Management:
   Negotiate with creditors to restructure or delay payments, easing short-term pressure.

3. Operational Review:
   Assess business model viability, considering whether to restart hiring or focus on revenue-generating activities.

4. Capital Restructuring:
   Consider increasing share capital or bringing in new investors to restore positive equity.

5. Financial Monitoring:
   Implement rigorous cash flow forecasting and monthly financial reviews to catch early signs of distress.

6. Professional Advice:
   Engage a turnaround specialist or insolvency practitioner early to explore options such as restructuring or formal protection if necessary.

---

Executive Summary